T. Rowe Price Investment Management, Inc. Relay Therapeutics, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $8.71 Million - $16.6 Million	-1,448,546 Reduced 64.0%	814,814 $8.97 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $417,382 - $763,320	41,780 Added 1.88%	2,263,360 $28.4 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $3.23 Million - $4.89 Million	215,039 Added 10.72%	2,221,580 $36.6 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $2.76 Million - $4.68 Million	194,938 Added 10.76%	2,006,541 $30 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $32.7 Million - $56.8 Million	1,811,603 New	1,811,603 $40.5 Million

187

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $834M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.